ARVN ARVINAS, INC.
company
SEC Filings & Insider Trading Activity 2026

CIK: 1655759
Health Care
Pharmaceutical Preparations 35 filings
Russell 2000

Latest ARVINAS, INC. (ARVN) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 24, 2026, a 10-Q quarterly report filed on November 5, 2025, an 8-K current report filed on May 1, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for ARVINAS, INC. (ARVN) (SEC CIK 1655759), with AI-powered section-by-section summaries updated daily.

10-Q: 22
10-K: 8
8-K: 5

Latest 2026 SEC Filing Dates

10-K Annual Report
Feb 24, 2026
10-Q Quarterly Report
Nov 5, 2025
8-K Current Report
May 1, 2026

AI 10-Q Quarterly Report Analysis
Latest 10-Q (2025-09-30)

Risk Factors

  • New operational risk: workforce reduction of ~48% in 2025 may disrupt clinical trials, commercialization, and increase attrition beyond planned staff cuts
  • Regulatory risk: FDA workforce cuts by 3,500 employees and budget uncertainties may delay regulatory submissions and approvals, disrupting product development
Read full Q3 2025 10-Q analysis →

AI 8-K Current Report Analysis
Recent 8-K Filings

Filed Mar 18, 2026
8-K
Full analysis →

Item 7.01: Regulation FD Disclosure

  • Positive Phase 1 data for ARV-102 showing >50% LRRK2 degradation in cerebrospinal fluid after 28 days in Parkinson’s patients
  • ARV-102 is an oral PROTAC designed to cross the blood-brain barrier targeting LRRK2, a key Parkinson's disease protein

Item 8.01: Other Events

  • Positive Phase 1 data for ARV-102 showing >50% LRRK2 degradation in CSF of Parkinson’s patients after 28 days treatment
  • ARV-102 well tolerated at 20 mg, 40 mg, 80 mg doses, no serious adverse events or lung function issues observed
Filed Feb 24, 2026
8-K
Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q4 and full-year 2025 results announced Feb 24, 2026; details in Exhibit 99.1 press release
  • Filing furnished (not filed), limiting legal liability under Exchange Act Section 18

Quarterly Reports Archive
10-Q

AI-powered analysis of ARVINAS, INC. (ARVN) 10-Q quarterly reports filed with SEC EDGAR.

Recent 8-K Filings
Current Reports

AI-powered analysis of ARVINAS, INC. (ARVN) 8-K current reports disclosing material events.

Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
May 1, 2026
8-K
Mar 18, 2026Analysis
8-K
Feb 24, 2026Analysis
10-K
Feb 24, 2026Dec 31, 2025
8-K
Feb 12, 2026
8-K
Dec 8, 2025
10-Q
Nov 5, 2025Sep 30, 2025Analysis
10-Q
Aug 6, 2025Jun 30, 2025
10-Q
May 1, 2025Mar 31, 2025
10-K
Feb 11, 2025Dec 31, 2024
10-Q
Oct 30, 2024Sep 30, 2024
10-Q
Jul 30, 2024Jun 30, 2024
10-Q
May 7, 2024Mar 31, 2024
10-K
Feb 27, 2024Dec 31, 2023
10-Q
Nov 7, 2023Sep 30, 2023
10-Q
Aug 8, 2023Jun 30, 2023
10-Q
May 5, 2023Mar 31, 2023
10-K
Feb 23, 2023Dec 31, 2022
10-Q
Nov 9, 2022Sep 30, 2022
10-Q
Aug 4, 2022Jun 30, 2022
10-Q
May 5, 2022Mar 31, 2022
10-K
Feb 28, 2022Dec 31, 2021
10-Q
Nov 3, 2021Sep 30, 2021
10-Q
Aug 5, 2021Jun 30, 2021
10-Q
May 4, 2021Mar 31, 2021

Frequently Asked Questions

What are the latest ARVN SEC filings in 2026?

ARVINAS, INC. (ARVN) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 5, 2025, an 8-K current report on May 1, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did ARVN file its most recent 10-K annual report?

ARVINAS, INC. (ARVN) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view ARVN 10-Q quarterly reports?

ARVINAS, INC. (ARVN)'s most recent 10-Q quarterly report was filed on November 5, 2025. SignalX displays every ARVN 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has ARVN filed recently?

ARVINAS, INC. (ARVN)'s most recent 8-K was filed on May 1, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find ARVN insider trading activity (Form 4)?

SignalX aggregates every ARVN Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does ARVN file with the SEC?

ARVINAS, INC. (ARVN) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ARVN filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for ARVINAS, INC. (ARVN).

What is ARVN's SEC CIK number?

ARVINAS, INC. (ARVN)'s SEC CIK (Central Index Key) number is 1655759. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1655759 to look up all ARVN filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find ARVN return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from ARVINAS, INC. (ARVN) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of ARVINAS, INC. SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 35+ filings.